GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of telehealth: the version I wish someone had shown me in week 1 — 29 comments in the full submission. View in context.
318
c/compounding·submitted 3 months ago by u/prior_auth_pain

telehealth: the version I wish someone had shown me in week 1

Questionbranch of 8 comments

Week 70 update. 31kg down from the start, muscle cramps basically gone since about week 27. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with muscle cramps. The part that surprised me is how much of this is admin.…

Read the full submission and all 29 comments →

This branch

8 comments, started 3 months ago
u/usp_appendixcompendial33 points·3 months ago

Mechanistically the bit that matters is API source. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/prior_auth_painOPappeals24 points·3 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/hugo_bergstrom16 points·3 months ago·edited

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/gustav_cardoso6 points·3 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/anya_antonsen20 points·3 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/ruben_cabrera15 points·3 months ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/prior_auth_painOPappeals0 points·3 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/prior_auth_painOPappeals13 points·3 months ago·edited

the Poland situation is different from the US, different regulations

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →